Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma
High-dose melphalan (Alkeran) and autologous stem cell transplantation are commonly incorporated into the initial line of therapy for patients newly diagnosed with multiple myeloma.